Table 1.
✓ Mimicry the human disease in |
➢ Local or disseminated aspergillosis |
➢ Time lapse of clinical course |
➢ Clinical outcome |
✓ Stability and inter-lab reproducibility |
✓ Ease of use for |
➢ Animal handling |
➢ Animal housing |
➢ Animal sampling |
✓ Availability of lab tools and reagents dedicated to |
✓ Reliable basis and background to address studies focusing on |
➢ Strain virulence and pathogenicity |
➢ Pathophysiology |
➢ Host immune response |
➢ Diagnostic tool(s) assessment |
➢ Imaging technology(-ies) assessment |
➢ Pharmacodynamics/pharmacokinetics/toxicology |
➢ Pre-clinical prophylactic assay(s) |
➢ Pre-clinical therapeutic assay(s) |
➢ Pre-clinical vaccine assay(s) |
✓ Low costs |
✓ Respect of ethical guidelines |
✓ Minimum standardization |
This above listing is probably not exhaustive, but it outlines the goals that are mostly thought to be critical for rodent support development in laboratories.